103 results
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
17 Apr 24
Current report (foreign)
9:30am
ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties affecting our
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
2 Apr 24
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
8:00am
on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
27 Mar 24
Evaxion Announces Business Update and Full Year 2023 Financial Results
8:30am
ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties affecting
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
19 Mar 24
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
8:17am
factors, including inflation, and the effects on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region
6-K
EX-99.1
5hax8x
29 Feb 24
Current report (foreign)
7:35am
6-K
EX-99.1
ofnools vyq5zvzd39x
20 Feb 24
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
7:32am
6-K
EX-99.1
cgg02lsa w84cp4
7 Feb 24
Current report (foreign)
8:30am
6-K
EX-99.1
irll1sd0ml2
6 Feb 24
Evaxion Announces Closing of $15 Million Public Offering
8:30am
6-K
EX-99.1
iyu0m4je4 vvuo
1 Feb 24
Evaxion Biotech Announces Pricing of $15 Million Public Offering
9:20am
F-1/A
fycvwhga2 e3k8
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
6-K
EX-99.1
ukzgs9qi
24 Jan 24
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
2:11pm
6-K
EX-99.1
vmrvmhm of
22 Jan 24
Evaxion Announces Completion of ADS Ratio Change
4:45pm
F-1
h6x6f26pxye
12 Jan 24
Registration statement (foreign)
5:17pm
6-K
EX-99.1
mip1ry
8 Jan 24
Evaxion Announces Plan to Implement ADS Ratio Change
8:30am
6-K
EX-99.2
d597536zrotm
21 Dec 23
Current report (foreign)
4:45pm
6-K
EX-99.1
r1e9g2ws1qnnl
19 Dec 23
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
4:45pm
6-K
EX-99.1
t6pw0crbih9omzknmf55
19 Dec 23
Evaxion Biotech Announces Private Placement Financing
8:45am
6-K
EX-99.1
e0p560arm6 orbixs
28 Nov 23
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
8:27am
6-K
EX-99.1
k0o5zbi
15 Nov 23
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
8:00am